Themis Medicare Limited — PPTs, 28-05-2026: Investor Presentation

Here's a concise summary of Themis Medicare's latest investor presentation:

1. **Business Performance:** Themis Medicare reported a strong Q4 FY26 comeback. Revenue grew 6.7% YoY to ₹76.5 Cr. EBITDA soared to ₹3.8 Cr (4.9% margin) from a ₹5.8 Cr loss last year, with PAT turning profitable at ₹8.9 Cr (11.6% margin) from a ₹9.7 Cr loss. Full-year FY26 revenue was ₹342.2 Cr, a dip from FY25, with modest EBITDA of ₹0.4 Cr and PAT of ₹1.14 Cr. Hospital business is now a major revenue driver (50% in FY26).

2. **Growth Drivers or Strategy:** The company is strategically focused on boosting profitability and cash flow by enhancing clinic effectiveness, targeted doctor outreach, and operational efficiencies. Key growth areas include expanding the high-potential Hospital business (Critical Care) and strengthening the API segment. They also plan international expansion into CIS, Latin America, GCC, then EU and USA.

3. **Recent Developments:** The Formulation business is undergoing strategic restructuring. Cost rationalization and improved productivity have driven better margins. Themis is actively expanding its presence in chain hospitals and nursing homes, focusing on higher-margin products.

4. **Key Financial Metrics:**

* Q4 FY26 Revenue: ₹76.5 Cr (+6.7% YoY)

* Q4 FY26 PAT: ₹8.9 Cr (vs loss of ₹9.7 Cr)

* Total Debt to Equity: 0.25

5. **Management Commentary / Outlook:** Management is optimistic, expecting future momentum from continued operational efficiencies, cost optimization, and gradual recovery across core segments, alongside efforts to improve cash flow.